References
- Pope-Harman AL, Davis WB, Allen ED, Christoforidis AJ, Allen JN. Acute eosinophilic pneumonia: a summary of 15 cases and review of the literature. Medicine (Baltimore) 1996;75(6):334–342. doi:https://doi.org/10.1097/00005792-199611000-00004.
- Rhee CK, Min KH, Yim NY, Lee JE, Lee NR, Chung MP, Jeon K. Clinical characteristics and corticosteroid treatment of acute eosinophilic pneumonia. Eur Respir J 2013;41(2):402–409. doi:https://doi.org/10.1183/09031936.00221811.
- Bartal C, Sagy I, Barski L. Drug-induced eosinophilic pneumonia: a review of 196 case reports. Medicine (Baltimore) 2018;97(4):e9688. doi:https://doi.org/10.1097/MD.0000000000009688.
- Papp KA, Langley RG, Lebwohl M, Krueger GG, Szapary P, Yeilding N, Guzzo C, Hsu M-C, Wang Y, Li S, et al. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2). Lancet 2008;71(9625):1675–1684 doi:https://doi.org/10.1016/S0140-6736(08)60726-6.
- Brinker A, Cheng C, Chan V. Association of noninfectious pneumonia with ustekinumab use. JAMA Dermatol 2019;155(2):221. doi:https://doi.org/10.1001/jamadermatol.2018.4118.
- Colbenson G, Nelson DR. A case of eosinophilic pneumonia secondary to ustekinumab in the treatment of Crohn's disease. Am J Respir Crit Care Med 2020;201:A1476.
- Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, et al. The American College of Rheumatology 1990 criteria for the classification of churg‐strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990;33(8):1094–1100. doi:https://doi.org/10.1002/art.1780330806.
- Jeong YJ, Kim K-I, Seo IJ, Lee CH, Lee KN, Kim KN, Kim JS, Kwon WJ. Eosinophilic lung diseases: a clinical, radiologic, and pathologic overview. Radiographics 2007;27(3):617–637. doi:https://doi.org/10.1148/rg.273065051.